share_log

Guggenheim Reiterates Buy on Century Therapeuticsto Buy

Benzinga ·  Mar 28 14:43

Guggenheim analyst Kelsey Goodwin reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 221

Recommended

Write a comment